Physician profile
John Stites
NPI 1114356599
$5,590.30
in general payments reported to CMS, 2019-2025
35 companies · $942 in 2025
The $942 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $876 · 2020: $176 · 2021: $1,319 · 2022: $527 · 2023: $1,011 · 2024: $740 · 2025: $942.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,692.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,692.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,308.06 | 2021-2025 | Urolift, Barrigel |
| Boston Scientific Corporation | $568.93 | 2019-2023 | Rezum Generator, Ams 700, Lithovue |
| Astellas Pharma US INC | $444.69 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $431.27 | 2023-2025 | Orgovyx, Gemtesa |
| Myriad Genetic Laboratories, INC. | $310.13 | 2021-2025 | Prolaris, Myrisk |
| Procept Biorobotics Corporation | $292.92 | 2019-2024 | Aquabeam System |
| Merck Sharp & Dohme LLC | $253.16 | 2019-2024 | Lynparza, Keytruda |
| Astrazeneca Pharmaceuticals Lp | $215.24 | 2020-2024 | Lynparza |
| Tempus Ai, INC | $189.09 | 2024-2025 | Xt Cdx |
| Bayer Healthcare Pharmaceuticals INC. | $171.16 | 2020-2025 | |
| Medtronic, INC. | $154.62 | 2022-2025 | Interstim |
| Richard Wolf Medical Instruments Corp. | $145.85 | 2019 | |
| Coloplast Corp | $130.21 | 2020-2025 | Titan |
| Pfizer INC. | $123.58 | 2019-2024 | |
| Endo Pharmaceuticals INC. | $84.38 | 2019-2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $79.69 | 2021-2023 | Axonics, Bulkamid |
| Olympus America INC. | $71.61 | 2021-2025 | Itind System |
| Urogen Pharma, INC. | $70.37 | 2022-2025 | |
| Dendreon Pharmaceuticals LLC | $60.17 | 2021-2024 | Provenge |
| Foundation Medicine, INC. | $40.08 | 2021 | |
| Neotract INC. | $36.75 | 2020 | |
| Baxter Healthcare | $31.61 | 2019-2020 | |
| Janssen Biotech, INC. | $31.18 | 2019-2024 | Erleada |
| Acerus Pharmaceuticals Corporation | $26.41 | 2020-2021 | |
| Endo USA, INC. | $24.55 | 2025 | Xiaflex |
| Verity Pharmaceuticals INC. | $24.40 | 2025 | Tlando |
| Blue Earth Diagnostics | $23.55 | 2019 | |
| Rochester Medical Corporation | $21.86 | 2021 | |
| Davol INC. | $20.04 | 2021 | |
| Lumenis, INC | $18.50 | 2021 | |
| Myovant Sciences INC. | $17.92 | 2022 | |
| Ferring Pharmaceuticals INC. | $17.71 | 2019 | |
| 180 Medical, INC. | $11.29 | 2019 | |
| Ambu INC. | $10.41 | 2021 | |
| Travere Therapeutics, INC. | $8.80 | 2021-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Stites listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.